1Torzewski J, Torzewski M, Bowyer DE, et al. C-reactive protein froquently colocalizes with the terminal complement comples in the ihtima of early atherosclerotic leisions of human coronary arteries[J]. Arterioscler Thromb Vasc Biol, 1988,18(9) : 1386-1392.
2Ridrer PM. High-sensitivity C-reactive porotein: ptential adjunct for global rlsr assessmentin the primary prevention of cardiovascular disease[J]. Circulation ,2001,103(12) : 1813-1818.
3Tillett WS, Fraecis T. Serological reactions in pneumonia with a nonprotein somatic of the pneumococcus [ J ]. JEXP Med, 1930, 52 (4) : 561-571.
4Thompson D, Pepys MB, Wood SP. The physiological Structure of human C-reactive protein and its complex with phosphocholine[ J].Structure Fold Des, 1999,7(2):169-177.
6Torzewsri M, Rist C, Mortensen RF, et al. C-reactive protein in the arterial intima:role of C-reactive protein receptor-dependent monocyterecruitment in atherogenesis[J]. Arterioscler Thromb Vasc Biol,2000,20(12) :2094-2099.
7Paserei V, Willerson JT, Yeh ET. Direct proinflammatory effect of C-reactive protein on human endothelial cells [ J ]. Circulation, 2000, 102(12) :2165-2168.
8Zwara TP, Hombaeh V, Torzewsri J. C-reactive protein mediated low density lipopvotein uptare by macrophages:implications for atherosclerosis[ J]. Circulation, 2001,103(7) : 1194-1197.
9Liuzzo G, Biasucci, LM, Gallimore JR, et al. The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina[J] .N Engl J Med, 1994,331(3) :417-424.
10Rebuzzi AG, Quarante L, Liuzzo G, et al. Incre mentalprognostic value of serum levels of tropinin T and. C-creactive protein on admisson in parients with unstable angina pectoris[J]. Am J Cardiol, 1998,82(5) :715-719.
2Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Nail Acad Sci USA, 2000, 97: 7458-7463.
3Lutgens E, Cleutjens KBJM, Heeneman S, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Nail Aced Sci. USA, 2000, 97: 7464-7469.
4Kai H,Ikeda H, Yasukawa H, et al. Perpherial blood levels of matrix metalloproteinase-2 and 9 are evelated In patients with acute coronary sndrome. J Am Coll Cardiol , 1998,32:368-372.
5Taku T, Toshio H, Hatsuyo K, et al. Cerivastatin, a HMG-CoA Reductase Inhibitor, Improves Endothelial Function In Elderly Diabetics winthin 3 days. Circulation, 2001,104:376-379.
6Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999,340: 115-126.
7Goran K Hansson. Immune Mechanism In Atherosclerosis Arteroscler Thromb Vasc Biol . 2001,21:1876-1890.
8Koefig W. Inflammation and coronary heart disease:an overview Cardiol Rev, 2001,9:31-35.
9Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 1997,96:396-399.
10Brown DL, Hibbs MS, Kearney M, et al. Identification 92 kDa gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation , 1995, 91: 2125-2131.
